Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
tilarginine (1 trial)
Shock (Phase 3)
Shock, Cardiogenic (Phase 3)
Trials (1 total)
Trial APIs (1 total)